Global Whole Cell Cholera Vaccine Market Research Report 2023

Whole Cell Cholera Vaccine is used to prevent Cholera.

The global Whole Cell Cholera Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries.

This report aims to provide a comprehensive presentation of the global market for Whole Cell Cholera Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Whole Cell Cholera Vaccine.

The Whole Cell Cholera Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Whole Cell Cholera Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Whole Cell Cholera Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Whole Cell Cholera Vaccine

1.2 Whole Cell Cholera Vaccine Segment by Type

1.2.1 Global Whole Cell Cholera Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 For Adults

1.2.3 For Children

1.3 Whole Cell Cholera Vaccine Segment by Application

1.3.1 Global Whole Cell Cholera Vaccine Market Value by Application: (2023-2029)

1.3.2 Clinical Research Institutes

1.3.3 Hospital

1.3.4 Surgical Centers

1.3.5 Others

1.4 Global Whole Cell Cholera Vaccine Market Size Estimates and Forecasts

1.4.1 Global Whole Cell Cholera Vaccine Revenue 2018-2029

1.4.2 Global Whole Cell Cholera Vaccine Sales 2018-2029

1.4.3 Global Whole Cell Cholera Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Whole Cell Cholera Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Whole Cell Cholera Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Whole Cell Cholera Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Whole Cell Cholera Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Whole Cell Cholera Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Whole Cell Cholera Vaccine, Product Type & Application

2.7 Whole Cell Cholera Vaccine Market Competitive Situation and Trends

2.7.1 Whole Cell Cholera Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Whole Cell Cholera Vaccine Players Market Share by Revenue

2.7.3 Global Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Whole Cell Cholera Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Whole Cell Cholera Vaccine Global Whole Cell Cholera Vaccine Sales by Region: 2018-2029

3.2.1 Global Whole Cell Cholera Vaccine Sales by Region: 2018-2023

3.2.2 Global Whole Cell Cholera Vaccine Sales by Region: 2024-2029

3.3 Global Whole Cell Cholera Vaccine Global Whole Cell Cholera Vaccine Revenue by Region: 2018-2029

3.3.1 Global Whole Cell Cholera Vaccine Revenue by Region: 2018-2023

3.3.2 Global Whole Cell Cholera Vaccine Revenue by Region: 2024-2029

3.4 North America Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.4.1 North America Whole Cell Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Whole Cell Cholera Vaccine Sales by Country (2018-2029)

3.4.3 North America Whole Cell Cholera Vaccine Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.5.1 Europe Whole Cell Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Whole Cell Cholera Vaccine Sales by Country (2018-2029)

3.5.3 Europe Whole Cell Cholera Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Whole Cell Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Whole Cell Cholera Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Whole Cell Cholera Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.7.1 Latin America Whole Cell Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Whole Cell Cholera Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Whole Cell Cholera Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Whole Cell Cholera Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Whole Cell Cholera Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Whole Cell Cholera Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Whole Cell Cholera Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Whole Cell Cholera Vaccine Sales by Type (2018-2029)

4.1.1 Global Whole Cell Cholera Vaccine Sales by Type (2018-2023)

4.1.2 Global Whole Cell Cholera Vaccine Sales by Type (2024-2029)

4.1.3 Global Whole Cell Cholera Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Whole Cell Cholera Vaccine Revenue by Type (2018-2029)

4.2.1 Global Whole Cell Cholera Vaccine Revenue by Type (2018-2023)

4.2.2 Global Whole Cell Cholera Vaccine Revenue by Type (2024-2029)

4.2.3 Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Whole Cell Cholera Vaccine Price by Type (2018-2029)

5.1 Global Whole Cell Cholera Vaccine Sales by Application (2018-2029)

5.1.1 Global Whole Cell Cholera Vaccine Sales by Application (2018-2023)

5.1.2 Global Whole Cell Cholera Vaccine Sales by Application (2024-2029)

5.1.3 Global Whole Cell Cholera Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Whole Cell Cholera Vaccine Revenue by Application (2018-2029)

5.2.1 Global Whole Cell Cholera Vaccine Revenue by Application (2018-2023)

5.2.2 Global Whole Cell Cholera Vaccine Revenue by Application (2024-2029)

5.2.3 Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Whole Cell Cholera Vaccine Price by Application (2018-2029)

6.1 SBL Vaccine

6.1.1 SBL Vaccine Corporation Information

6.1.2 SBL Vaccine Description and Business Overview

6.1.3 SBL Vaccine Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 SBL Vaccine Whole Cell Cholera Vaccine Product Portfolio

6.1.5 SBL Vaccine Recent Developments/Updates

6.2 PaxVax

6.2.1 PaxVax Corporation Information

6.2.2 PaxVax Description and Business Overview

6.2.3 PaxVax Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 PaxVax Whole Cell Cholera Vaccine Product Portfolio

6.2.5 PaxVax Recent Developments/Updates

6.3 Valneva SE

6.3.1 Valneva SE Corporation Information

6.3.2 Valneva SE Description and Business Overview

6.3.3 Valneva SE Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Valneva SE Whole Cell Cholera Vaccine Product Portfolio

6.3.5 Valneva SE Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Corporation Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 GlaxoSmithKline Whole Cell Cholera Vaccine Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Johnson and Johnson

6.5.1 Johnson and Johnson Corporation Information

6.5.2 Johnson and Johnson Description and Business Overview

6.5.3 Johnson and Johnson Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Johnson and Johnson Whole Cell Cholera Vaccine Product Portfolio

6.5.5 Johnson and Johnson Recent Developments/Updates

6.6 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Merck Whole Cell Cholera Vaccine Product Portfolio

6.6.5 Merck Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Pfizer Whole Cell Cholera Vaccine Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Sanofi Pasteur

6.8.1 Sanofi Pasteur Corporation Information

6.8.2 Sanofi Pasteur Description and Business Overview

6.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Sanofi Pasteur Whole Cell Cholera Vaccine Product Portfolio

6.8.5 Sanofi Pasteur Recent Developments/Updates

6.9 AstraZeneca(Medimmune, LLC.)

6.9.1 AstraZeneca(Medimmune, LLC.) Corporation Information

6.9.2 AstraZeneca(Medimmune, LLC.) Description and Business Overview

6.9.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product Portfolio

6.9.5 AstraZeneca(Medimmune, LLC.) Recent Developments/Updates

6.10 Serum Institute of India

6.10.1 Serum Institute of India Corporation Information

6.10.2 Serum Institute of India Description and Business Overview

6.10.3 Serum Institute of India Whole Cell Cholera Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Serum Institute of India Whole Cell Cholera Vaccine Product Portfolio

6.10.5 Serum Institute of India Recent Developments/Updates

7.1 Whole Cell Cholera Vaccine Industry Chain Analysis

7.2 Whole Cell Cholera Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Whole Cell Cholera Vaccine Production Mode & Process

7.4 Whole Cell Cholera Vaccine Sales and Marketing

7.4.1 Whole Cell Cholera Vaccine Sales Channels

7.4.2 Whole Cell Cholera Vaccine Distributors

7.5 Whole Cell Cholera Vaccine Customers

8.1 Whole Cell Cholera Vaccine Industry Trends

8.2 Whole Cell Cholera Vaccine Market Drivers

8.3 Whole Cell Cholera Vaccine Market Challenges

8.4 Whole Cell Cholera Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Whole Cell Cholera Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Whole Cell Cholera Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Whole Cell Cholera Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Whole Cell Cholera Vaccine Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Whole Cell Cholera Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Whole Cell Cholera Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Whole Cell Cholera Vaccine Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Whole Cell Cholera Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Whole Cell Cholera Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Whole Cell Cholera Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Whole Cell Cholera Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Whole Cell Cholera Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Whole Cell Cholera Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Whole Cell Cholera Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Whole Cell Cholera Vaccine Sales by Region (2018-2023) & (K Units)

    Table 18. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Whole Cell Cholera Vaccine Sales by Region (2024-2029) & (K Units)

    Table 20. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Whole Cell Cholera Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Whole Cell Cholera Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Whole Cell Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Whole Cell Cholera Vaccine Sales by Country (2018-2023) & (K Units)

    Table 27. North America Whole Cell Cholera Vaccine Sales by Country (2024-2029) & (K Units)

    Table 28. North America Whole Cell Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Whole Cell Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Whole Cell Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Whole Cell Cholera Vaccine Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Whole Cell Cholera Vaccine Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Whole Cell Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Whole Cell Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Whole Cell Cholera Vaccine Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Whole Cell Cholera Vaccine Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Whole Cell Cholera Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Whole Cell Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Whole Cell Cholera Vaccine Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Whole Cell Cholera Vaccine Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Whole Cell Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Whole Cell Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Whole Cell Cholera Vaccine Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Whole Cell Cholera Vaccine Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Whole Cell Cholera Vaccine Sales (K Units) by Type (2018-2023)

    Table 51. Global Whole Cell Cholera Vaccine Sales (K Units) by Type (2024-2029)

    Table 52. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Whole Cell Cholera Vaccine Sales (K Units) by Application (2018-2023)

    Table 61. Global Whole Cell Cholera Vaccine Sales (K Units) by Application (2024-2029)

    Table 62. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Whole Cell Cholera Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Application (2024-2029)

    Table 70. SBL Vaccine Corporation Information

    Table 71. SBL Vaccine Description and Business Overview

    Table 72. SBL Vaccine Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. SBL Vaccine Whole Cell Cholera Vaccine Product

    Table 74. SBL Vaccine Recent Developments/Updates

    Table 75. PaxVax Corporation Information

    Table 76. PaxVax Description and Business Overview

    Table 77. PaxVax Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. PaxVax Whole Cell Cholera Vaccine Product

    Table 79. PaxVax Recent Developments/Updates

    Table 80. Valneva SE Corporation Information

    Table 81. Valneva SE Description and Business Overview

    Table 82. Valneva SE Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Valneva SE Whole Cell Cholera Vaccine Product

    Table 84. Valneva SE Recent Developments/Updates

    Table 85. GlaxoSmithKline Corporation Information

    Table 86. GlaxoSmithKline Description and Business Overview

    Table 87. GlaxoSmithKline Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. GlaxoSmithKline Whole Cell Cholera Vaccine Product

    Table 89. GlaxoSmithKline Recent Developments/Updates

    Table 90. Johnson and Johnson Corporation Information

    Table 91. Johnson and Johnson Description and Business Overview

    Table 92. Johnson and Johnson Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Johnson and Johnson Whole Cell Cholera Vaccine Product

    Table 94. Johnson and Johnson Recent Developments/Updates

    Table 95. Merck Corporation Information

    Table 96. Merck Description and Business Overview

    Table 97. Merck Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Merck Whole Cell Cholera Vaccine Product

    Table 99. Merck Recent Developments/Updates

    Table 100. Pfizer Corporation Information

    Table 101. Pfizer Description and Business Overview

    Table 102. Pfizer Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Pfizer Whole Cell Cholera Vaccine Product

    Table 104. Pfizer Recent Developments/Updates

    Table 105. Sanofi Pasteur Corporation Information

    Table 106. Sanofi Pasteur Description and Business Overview

    Table 107. Sanofi Pasteur Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Sanofi Pasteur Whole Cell Cholera Vaccine Product

    Table 109. Sanofi Pasteur Recent Developments/Updates

    Table 110. AstraZeneca(Medimmune, LLC.) Corporation Information

    Table 111. AstraZeneca(Medimmune, LLC.) Description and Business Overview

    Table 112. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product

    Table 114. AstraZeneca(Medimmune, LLC.) Recent Developments/Updates

    Table 115. Serum Institute of India Corporation Information

    Table 116. Serum Institute of India Description and Business Overview

    Table 117. Serum Institute of India Whole Cell Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Serum Institute of India Whole Cell Cholera Vaccine Product

    Table 119. Serum Institute of India Recent Developments/Updates

    Table 120. Key Raw Materials Lists

    Table 121. Raw Materials Key Suppliers Lists

    Table 122. Whole Cell Cholera Vaccine Distributors List

    Table 123. Whole Cell Cholera Vaccine Customers List

    Table 124. Whole Cell Cholera Vaccine Market Trends

    Table 125. Whole Cell Cholera Vaccine Market Drivers

    Table 126. Whole Cell Cholera Vaccine Market Challenges

    Table 127. Whole Cell Cholera Vaccine Market Restraints

    Table 128. Research Programs/Design for This Report

    Table 129. Key Data Information from Secondary Sources

    Table 130. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Whole Cell Cholera Vaccine

    Figure 2. Global Whole Cell Cholera Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Whole Cell Cholera Vaccine Market Share by Type in 2022 & 2029

    Figure 4. For Adults Product Picture

    Figure 5. For Children Product Picture

    Figure 6. Global Whole Cell Cholera Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Whole Cell Cholera Vaccine Market Share by Application in 2022 & 2029

    Figure 8. Clinical Research Institutes

    Figure 9. Hospital

    Figure 10. Surgical Centers

    Figure 11. Others

    Figure 12. Global Whole Cell Cholera Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Whole Cell Cholera Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Whole Cell Cholera Vaccine Sales (2018-2029) & (K Units)

    Figure 15. Global Whole Cell Cholera Vaccine Average Price (USD/Unit) & (2018-2029)

    Figure 16. Whole Cell Cholera Vaccine Report Years Considered

    Figure 17. Whole Cell Cholera Vaccine Sales Share by Manufacturers in 2022

    Figure 18. Global Whole Cell Cholera Vaccine Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Whole Cell Cholera Vaccine Players: Market Share by Revenue in 2022

    Figure 20. Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Whole Cell Cholera Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Whole Cell Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 23. North America Whole Cell Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Whole Cell Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 27. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Whole Cell Cholera Vaccine Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Whole Cell Cholera Vaccine Revenue Market Share by Region (2018-2029)

    Figure 35. China Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Whole Cell Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Whole Cell Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Whole Cell Cholera Vaccine Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. U.A.E Whole Cell Cholera Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Whole Cell Cholera Vaccine by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Whole Cell Cholera Vaccine by Type (2018-2029)

    Figure 57. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Whole Cell Cholera Vaccine by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Whole Cell Cholera Vaccine by Application (2018-2029)

    Figure 60. Global Whole Cell Cholera Vaccine Price (USD/Unit) by Application (2018-2029)

    Figure 61. Whole Cell Cholera Vaccine Value Chain

    Figure 62. Whole Cell Cholera Vaccine Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed